American Shared Hosp | 8-K: FY2025 Q2 Revenue: USD 7.071 M

Revenue: As of FY2025 Q2, the actual value is USD 7.071 M.

EPS: As of FY2025 Q2, the actual value is USD -0.04.

Segment Revenue

• Total Revenue: For Q2 2025, total revenue was $7,071,000, a 0.2% increase from $7,056,000 in Q2 2024.
• Direct Patient Services: Revenue was $3,500,000 for Q2 2025, an 11% increase from the prior year, driven by the Rhode Island centers and the new facility in Puebla, Mexico.
• Medical Equipment Leasing: Revenue decreased 8% to $3,571,000 for Q2 2025 compared to $3,899,000 in Q2 2024, due to lower Gamma Knife volumes and the expiration of three customer contracts.
• Proton Beam Radiation Therapy: Revenue decreased to $1,921,000 in Q2 2025 from $2,420,000 in Q2 2024, due to lower volumes.

Operational Metrics

• Gross Margin: For Q2 2025, gross margin was $1,630,000, down from $2,468,000 in Q2 2024, primarily due to lower treatment volumes.
• Net Loss: The net loss attributable to American Shared Hospital Services for Q2 2025 was -$280,000 or -$0.04 per share, compared to net income of $3,602,000 or $0.55 per diluted share in Q2 2024.
• Adjusted EBITDA: Adjusted EBITDA was $1,701,000 for Q2 2025, compared to $2,010,000 in Q2 2024.

Cash Flow

• Cash, Cash Equivalents, and Restricted Cash: As of June 30, 2025, the total was $11,331,000, compared to $11,275,000 at December 31, 2024.

Outlook / Guidance

• The company expects further long-term growth from the new Esprit installation in Guadalajara, Mexico, expected to start in late 2025. Additionally, recent Certificate of Need approvals for new treatment centers in Rhode Island are expected to expand the company’s footprint and growth potential. The company remains focused on strategic initiatives to improve efficiency and leverage economies of scale for profitability.